Abstract
Epigenetic genome modifications such as DNA methylation appear to be involved in various diseases. Here, we suggest that the levels of DNA methylation at the BssHII methylation-sensitive restriction enzyme sites in the human REELIN (RELN) gene in the forebrain vary among individuals. Interestingly, although a statistically significant correlation between the levels of DNA methylation in RELN and age was detected in healthy individuals, no such correlations were seen in either schizophrenic or bipolar patients. In addition, reverse correlations between DNA methylation levels and RELN expression were also detected in postmortem brain RNA and on in vitro assay. These data suggest the possibility that epigenetic aberration from the normal DNA methylation status of RELN may confer susceptibility to psychiatric disorders.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Bird A . DNA methylation patterns and epigenetic memory. Genes Dev 2002; 16: 6–21.
Jaenisch R, Bird A . Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 2003; 33 (Suppl): 245–254.
Robertson KD . DNA methylation and human disease. Nat Rev Genet 2005; 6: 597–610.
Grayson DR, Jia X, Chen Y, Sharma RP, Mitchell CP, Guidotti A et al. Reelin promoter hypermethylation in schizophrenia. Proc Natl Acad Sci USA 2005; 102: 9341–9346.
Chen Y, Sharma RP, Costa RH, Costa E, Grayson DR . On the epigenetic regulation of the human reelin promoter. Nucleic Acids Res 2002; 30: 2930–2939.
Abdolmaleky HM, Cheng KH, Russo A, Smith CL, Faraone SV, Wilcox M et al. Hypermethylation of the reelin (RELN) promoter in the brain of schizophrenic patients: a preliminary report. Am J Med Genet B Neuropsychiatr Genet 2005; 134: 60–66.
Dong E, Agis-Balboa RC, Simonini MV, Grayson DR, Costa E, Guidotti A . Reelin and glutamic acid decarboxylase67 promoter remodeling in an epigenetic methionine-induced mouse model of schizophrenia. Proc Natl Acad Sci USA 2005; 102: 12578–12583.
Popendikyte V, Laurinavicius A, Paterson AD, Macciardi F, Kennedy JL, Petronis A . DNA methylation at the putative promoter region of the human dopamine D2 receptor gene. Neuroreport 1999; 10: 1249–1255.
Hohjoh H, Singer MF . Cytoplasmic ribonucleoprotein complexes containing human LINE-1 protein and RNA. Embo J 1996; 15: 630–639.
Fatemi SH, Earle JA, McMenomy T . Reduction in Reelin immunoreactivity in hippocampus of subjects with schizophrenia, bipolar disorder and major depression. Mol Psychiatry 2000; 5: 654–663, 571.
Fatemi SH, Emamian ES, Kist D, Sidwell RW, Nakajima K, Akhter P et al. Defective corticogenesis and reduction in Reelin immunoreactivity in cortex and hippocampus of prenatally infected neonatal mice. Mol Psychiatry 1999; 4: 145–154.
Impagnatiello F, Guidotti AR, Pesold C, Dwivedi Y, Caruncho H, Pisu MG et al. A decrease of reelin expression as a putative vulnerability factor in schizophrenia. Proc Natl Acad Sci USA 1998; 95: 15718–15723.
Guidotti A, Auta J, Davis JM, Di-Giorgi-Gerevini V, Dwivedi Y, Grayson DR et al. Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study. Arch Gen Psychiatry 2000; 57: 1061–1069.
Eastwood SL, Harrison PJ . Interstitial white matter neurons express less reelin and are abnormally distributed in schizophrenia: towards an integration of molecular and morphologic aspects of the neurodevelopmental hypothesis. Mol Psychiatry 2003; 8: 769, 821–831.
Noh JS, Sharma RP, Veldic M, Salvacion AA, Jia X, Chen Y et al. DNA methyltransferase 1 regulates reelin mRNA expression in mouse primary cortical cultures. Proc Natl Acad Sci USA 2005; 102: 1749–1754.
Ekelund J, Lichtermann D, Hovatta I, Ellonen P, Suvisaari J, Terwilliger JD et al. Genome-wide scan for schizophrenia in the Finnish population: evidence for a locus on chromosome 7q22. Hum Mol Genet 2000; 9: 1049–1057.
Acknowledgements
We thank Drs Michael B Knable, E Fuller Torrey, Maree J Webster, and Robert H Yolken in the Stanley Medical Research Institute for kindly providing genomic DNA and RNA samples. We also thank H Kimura and K Kaneko for their encouragement. This work was supported in part by research grants from the Ministry of Health, Labor, Welfare in Japan, and by a Grant-in-Aid from the Japan Society for the Promotion of Science.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tamura, Y., Kunugi, H., Ohashi, J. et al. Epigenetic aberration of the human REELIN gene in psychiatric disorders. Mol Psychiatry 12, 593–600 (2007). https://doi.org/10.1038/sj.mp.4001965
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.mp.4001965
Keywords
This article is cited by
-
Expression Pattern of Long Non-coding RNAs in Schizophrenic Patients
Cellular and Molecular Neurobiology (2019)
-
Convergent Lines of Evidence Support LRP8 as a Susceptibility Gene for Psychosis
Molecular Neurobiology (2016)
-
DNA methylation in schizophrenia: progress and challenges
Science Bulletin (2015)